↓ Skip to main content

Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa

Overview of attention for article published in BMC Infectious Diseases, August 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent
6 patents
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
92 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
Published in
BMC Infectious Diseases, August 2007
DOI 10.1186/1471-2334-7-99
Pubmed ID
Authors

Stephen D Lawn, Nonzwakazi Bangani, Monica Vogt, Linda-Gail Bekker, Motasim Badri, Marjorie Ntobongwana, Hazel M Dockrell, Robert J Wilkinson, Robin Wood

Abstract

Interferon-gamma (IFN-gamma) ELISPOT assays incorporating Mycobacterium tuberculosis-specific antigens are useful in the diagnosis of tuberculosis (TB) or latent infection. However, their utility in patients with advanced HIV is unknown. We studied determinants of ELISPOT responses among patients with advanced HIV infection (but without active TB) living in a South African community with very high TB notification rates.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
South Africa 2 2%
Portugal 1 1%
Brazil 1 1%
Germany 1 1%
India 1 1%
Switzerland 1 1%
Unknown 82 89%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 27%
Student > Ph. D. Student 14 15%
Student > Master 13 14%
Student > Doctoral Student 6 7%
Student > Bachelor 6 7%
Other 20 22%
Unknown 8 9%
Readers by discipline Count As %
Medicine and Dentistry 40 43%
Agricultural and Biological Sciences 13 14%
Immunology and Microbiology 11 12%
Nursing and Health Professions 7 8%
Social Sciences 6 7%
Other 8 9%
Unknown 7 8%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 November 2023.
All research outputs
#3,272,132
of 22,787,797 outputs
Outputs from BMC Infectious Diseases
#1,094
of 7,671 outputs
Outputs of similar age
#7,987
of 68,764 outputs
Outputs of similar age from BMC Infectious Diseases
#4
of 15 outputs
Altmetric has tracked 22,787,797 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,671 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 68,764 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.